The CSHL Fellows program began with CSHL Professor Adrian Krainer, a shining example of the importance of investing in early career scientists. His research was used for the development of Spinraza, the first approved drug for spinal muscular atrophy (SMA).
#SMAAwareness #ScienceMakesLifeBetter
